|
GLYR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.082360E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.439800E-02 |
| Normal-vs-Stage2 |
4.657800E-01 |
| Normal-vs-Stage3 |
1.783980E-03 |
| Normal-vs-Stage4 |
3.057100E-03 |
| Stage1-vs-Stage2 |
2.249200E-01 |
| Stage1-vs-Stage3 |
1.963180E-01 |
| Stage1-vs-Stage4 |
3.005800E-01 |
| Stage2-vs-Stage3 |
4.634300E-02 |
| Stage2-vs-Stage4 |
7.107700E-02 |
| Stage3-vs-Stage4 |
9.622600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.384900E-03 |
| Normal-vs-AfricanAmerican |
6.472000E-01 |
| Normal-vs-Asian |
4.444000E-02 |
| Caucasian-vs-AfricanAmerican |
1.676590E-01 |
| Caucasian-vs-Asian |
8.903600E-01 |
| AfricanAmerican-vs-Asian |
2.564400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.397100E-03 |
| Normal-vs-Female |
1.918430E-02 |
| Male-vs-Female |
4.509000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.262500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.022400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.167600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.925900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.135800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.216200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.441800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.530200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.298200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.305600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.935950E-02 |
| Classical-VS-Follicular |
8.326400E-01 |
| Classical-VS-Other |
2.288000E-01 |
| Classical-VS-Normal |
4.009800E-02 |
| Tall-VS-Follicular |
9.200000E-02 |
| Tall-VS-Other |
7.586000E-01 |
| Tall-VS-Normal |
1.104890E-03 |
| Follicular-VS-Other |
3.678600E-01 |
| Follicular-VS-Normal |
6.703900E-02 |
| Other-VS-Normal |
3.669800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.178100E-02 |
| Normal-vs-N1 |
1.640560E-04 |
| N0-vs-N1 |
2.946200E-02 |
|
|
